News

SCAI Ad Hoc PCI Stenting Cath Lab Clinical Trial

When tests reveal that a patient’s heart artery is blocked and blood flow to the heart is restricted, should the doctor fix it with a stent or stop the test and discuss treatment options with the...

TAVR Millenium Market Research Group

According to Millennium Research Group (MRG), approximately 80 percent of transcatheter aortic valve replacement (TAVR) procedures are being performed on high-risk patients who are ineligible for...

Merge Hemo 2012 Best in KLAS Awards: Software & Services hemodynamic monitoring

Merge Healthcare Inc. announced that Merge Hemo has been named the "Category Leader" in the "2012 Best in KLAS Awards: Software & Services" report for Cardiology Hemodynamics rankings for the...

Cerebral Angioplasty Stents Radiology Stroke treatment devices

Some stroke patients may benefit from cerebral angioplasty and stent placement, according to a new study published online in the journal Radiology.

Among deployed U.S. service members who died of combat or unintentional injuries between 2001-2011 and underwent autopsies, the prevalence of coronary atherosclerosis was 8.5 percent, with factors...

Top Cardiovascular Stories 2012 Software CT angiography Heart Valve Repair

The past year in cardiology has continued to see progress and innovation in medicine. As the year comes to an end, the American College of Cardiology (ACC) identified some of the top...

2012 Top 10 Advances in Heart Disease and Stroke Research

Resuscitation, cell regeneration, a new high blood pressure treatment and developments in devices for treating stroke are among the key scientific findings that make up this year's top...

December 27, 2012 — Cardiosonic Inc., a private developer of technology in the field of renal denervation for the treatment of hypertension, announced it has closed on the first $6.1 million of a...

December 27, 2012 — Biotronik announced that the first implant has taken place in the BIOHELIX-I trial in the United States. The BIOHELIX–I trial is set to evaluate the safety and...

According to Millennium Research Group (MRG), a company focused on global medical technology market intelligence, approximately 80 percent of transcatheter aortic valve replacement (TAVR)...

December 26, 2012 — St. Jude Medical Inc. announced the first patient enrollment in its ILUMIEN I clinical study. The observational study is designed to show the optimal way optical coherence...

December 26, 2012 — Flexible Stenting Solutions Inc. (FSS) announced it gained CE mark in the European Union for its 6 French Reconstrainable FlexStent Femoropopliteal self-expanding...

December 26, 2012 — Covidien announced a definitive agreement to acquire CV Ingenuity. The companies expect to complete the acquisition in the first calendar quarter of 2013. Financial...

RealView's 3-D holographic projection of a heart

The annual Transcatheter Cardiovascular Therapeutics (TCT) meeting brings many cutting-edge technologies to the forefront during its five days of clinical sessions. This is my editor’s choice of...

Despite earlier signs that a less-invasive surgery is safer and better than “open” operations to repair potentially lethal abdominal aortic aneurysms, a clinical study led by a Johns Hopkins...

December 21, 2012 — Covidien announced the five-year results of the ClosureFast long-term European multicenter study in patients with chronic venous insufficiency (CVI). This study evaluates...

The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and the public that the anticoagulant Pradaxa (dabigatran etexilate mesylate) should not be used to prevent stroke...

December 19, 2012 — The first patient has been enrolled in the Boston Scientific EVOLVE II clinical trial, which is designed to further assess the safety and effectiveness of the Synergy ...

New streamlined guidelines will help healthcare providers better treat patients with the most severe type of heart attacks, according to an American Heart Association/American College of...

One Snare Endovascular Snare System Merit Medical Systems

Merit Medical Systems Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the One Snare Endovascular Snare System.